関連レポート

リキッドバイオプシー（液体生検）の世界市場：循環バイオマーカー別、用途別2027年予測

サイト内検索

お探しの資料等をキーワード検索できます。英語検索も有効です。

出版元：Transparency Market Research 　 出版元について

発行年：2023年12月

定価 ：Single User License(1名様ライセンス)US$5,795(米国ドル)/Multi User License(5名様)$8,795 /Enterprise License $11,705

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

ご請求は円換算（お見積り日TTSレート）となります。

納品形態：PDF by Email

当調査レポートは英文161ページになります。

商品コード：TMR152

【レポート紹介】

液体生検（リキッドバイオプシー）の世界市場規模は2022年で37億ドル、2031年に77億ドル、市場の平均年成長率は8.8%に拡大する見通しです。

当レポートでは、液体生検の市場予測-2031年、各種セグメント別市場分析(用途別、エンドユーザー別、国地域別、等)、SWOT分析、バリューチェーン分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

■液体生検の世界市場予測2017-2031年

・市場規模(US$)

■用途別、市場-2031年

腫瘍学
NIPT検査
移植診断
その他
※(市場規模US$)

■循環バイオマーカー別、市場-2031年

循環腫瘍細胞（CTC）
遊離核酸
細胞外小胞/エクソソーム
※(市場規模US$)

■エンドユーザー別、市場-2031年

病院薬局
小売薬局
オンライン販売
※(市場規模US$)

■主要国地域別市場-2031年

北米
・米国、カナダ
・その他北米
欧州
・英国、ドイツ、フランス
・その他欧州
アジア太平洋
・日本、中国
・その他アジア太平洋
中東アフリカ
・GCC諸国
・その他中東アフリカ
南米
・ブラジル
・その他南米
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析

市場ダイナミクス（促進要因、障壁、機会）
業界構造分析
SWOT分析
バリューチェーン分析
競合状況
市場シェア分析

■液体生検の主要企業プロフィール動向

Biocept, Inc.
MDxHealth
Myriad Genetics, Inc.
Bio-Rad Laboratories
QIAGEN
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific, Inc.,
Genomic Health, Inc.
Illumina, Inc.

（全161頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

1. Preface

    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions
3. Research Methodology
4. Executive Summary
5. Market Overview

    5.1. Introduction
    5.2. Market Dynamics
        5.2.1. Drivers
        5.2.2. Restraints
        5.2.3. Opportunities
    5.3. Key Trends Analysis
        5.3.1. Demand Side Analysis
        5.3.2. Supply Side Analysis
    5.4. Key Market Indicators
    5.5. Technological Overview Analysis
    5.6. Porter’s Five Forces Analysis
    5.7. Industry SWOT Analysis
    5.8. Value Chain Analysis
    5.9. Regulatory Framework
    5.10. Global Liquid Biopsy Market Analysis and Forecast, - 2017–2031
        5.10.1. Market Value Projections (US$ Mn)

6. Global Liquid Biopsy Market Analysis and Forecast, by Application

    6.1. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017–2031
        6.1.1. Oncology
        6.1.2. NIPT
        6.1.3. Transplant Diagnostics
        6.1.4. Others
    6.2. Incremental Opportunity, by Application

7. Global Liquid Biopsy Market Analysis and Forecast, by Circulating Biomarker

    7.1. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017–2031
        7.1.1. Circulating Tumor Cells (CTC)
        7.1.2. Free Nucleic Acid
        7.1.3. Exracellular Vesicles/Exosomes
    7.2. Incremental Opportunity, by Circulating Biomarker

8. Global Liquid Biopsy Market Analysis and Forecast, by End-user

    8.1. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017–2031
        8.1.1. Hospitals
        8.1.2. Reference Laboratories
        8.1.3. Academic and Research Institutes
        8.1.4. Others
    8.2. Incremental Opportunity, by End-user

9. Global Liquid Biopsy Market Analysis and Forecast, by Region

    9.1. Liquid Biopsy Market Size (US$ Mn) Forecast, by Region, 2017–2031
        9.1.1. North America
        9.1.2. Europe
        9.1.3. Asia Pacific
        9.1.4. Middle East & Africa
        9.1.5. South America
    9.2. Incremental Opportunity, by Region

10. North America Liquid Biopsy Market Analysis and Forecast

    10.1. Regional Snapshot
    10.2. Brand Analysis
    10.3. Price Trend Analysis
        10.3.1. Weighted Average Price
    10.4. Key Trends Analysis
        10.4.1. Demand Side
        10.4.2. Supplier Side
    10.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017–2031
        10.5.1. Oncology
        10.5.2. NIPT
        10.5.3. Transplant Diagnostics
        10.5.4. Others
    10.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017–2031
        10.6.1. Circulating Tumor Cells (CTC)
        10.6.2. Free Nucleic Acid
        10.6.3. Exracellular Vesicles/Exosomes
    10.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user - 2017–2031
        10.7.1. Hospitals
        10.7.2. Reference Laboratories
        10.7.3. Academic and Research Institutes
        10.7.4. Others
    10.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country - 2017–2031
        10.8.1. U.S.
        10.8.2. Canada
        10.8.3. Rest of North America
    10.9. Incremental Opportunity Analysis

11. Europe Liquid Biopsy Market Analysis and Forecast

    11.1. Regional Snapshot
    11.2. Brand Analysis
    11.3. Price Trend Analysis
        11.3.1. Weighted Average Price
    11.4. Key Trends Analysis
        11.4.1. Demand Side
        11.4.2. Supplier Side
    11.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017–2031
        11.5.1. Oncology
        11.5.2. NIPT
        11.5.3. Transplant Diagnostics
        11.5.4. Others
    11.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017–2031
        11.6.1. Circulating Tumor Cells (CTC)
        11.6.2. Free Nucleic Acid
        11.6.3. Exracellular Vesicles/Exosomes
    11.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017–2031
        11.7.1. Hospitals
        11.7.2. Reference Laboratories
        11.7.3. Academic and Research Institutes
        11.7.4. Others
    11.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017–2031
        11.8.1. U.K.
        11.8.2. Germany
        11.8.3. France
        11.8.4. Rest of Europe
    11.9. Incremental Opportunity Analysis

12. Asia Pacific Liquid Biopsy Market Analysis and Forecast

    12.1. Regional Snapshot
    12.2. Brand Analysis
    12.3. Price Trend Analysis
        12.3.1. Weighted Average Price
    12.4. Key Trends Analysis
        12.4.1. Demand Side
        12.4.2. Supplier Side
    12.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017–2031
        12.5.1. Oncology
        12.5.2. NIPT
        12.5.3. Transplant Diagnostics
        12.5.4. Others
    12.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017–2031
        12.6.1. Circulating Tumor Cells (CTC)
        12.6.2. Free Nucleic Acid
        12.6.3. Exracellular Vesicles/Exosomes
    12.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017–2031
        12.7.1. Hospitals
        12.7.2. Reference Laboratories
        12.7.3. Academic and Research Institutes
        12.7.4. Others
    12.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017–2031
        12.8.1. India
        12.8.2. China
        12.8.3. Japan
        12.8.4. Rest of Asia Pacific
    12.9. Incremental Opportunity Analysis

13. Middle East & South Africa Liquid Biopsy Market Analysis and Forecast

    13.1. Regional Snapshot
    13.2. Brand Analysis
    13.3. Price Trend Analysis
        13.3.1. Weighted Average Price
    13.4. Key Trends Analysis
        13.4.1. Demand Side
        13.4.2. Supplier Side
    13.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017–2031
        13.5.1. Oncology
        13.5.2. NIPT
        13.5.3. Transplant Diagnostics
        13.5.4. Others
    13.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017–2031
        13.6.1. Circulating Tumor Cells (CTC)
        13.6.2. Free Nucleic Acid
        13.6.3. Exracellular Vesicles/Exosomes
    13.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017–2031
        13.7.1. Hospitals
        13.7.2. Reference Laboratories
        13.7.3. Academic and Research Institutes
        13.7.4. Others
    13.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017–2031
        13.8.1. GCC
        13.8.2. Rest of Middle East & Africa
    13.9. Incremental Opportunity Analysis

14. South America Liquid Biopsy Market Analysis and Forecast

    14.1. Regional Snapshot
    14.2. Brand Analysis
    14.3. Price Trend Analysis
        14.3.1. Weighted Average Price
    14.4. Key Trends Analysis
        14.4.1. Demand Side
        14.4.2. Supplier Side
    14.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017–2031
        14.5.1. Oncology
        14.5.2. NIPT
        14.5.3. Transplant Diagnostics
        14.5.4. Others
    14.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017–2031
        14.6.1. Circulating Tumor Cells (CTC)
        14.6.2. Free Nucleic Acid
        14.6.3. Exracellular Vesicles/Exosomes
    14.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017–2031
        14.7.1. Hospitals
        14.7.2. Reference Laboratories
        14.7.3. Academic and Research Institutes
        14.7.4. Others
    14.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017–2031
        14.8.1. Brazil
        14.8.2. Rest of South America
    14.9. Incremental Opportunity Analysis

15. Competition Landscape

    15.1. Market Player - Competition Dashboard
    15.2. Market Share Analysis (%), by Company, (2022)
    15.3. Company Profiles (Details - Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
        15.3.1. Biocept, Inc.
            15.3.1.1. Company Overview
            15.3.1.2. Sales Area
            15.3.1.3. Geographical Presence
            15.3.1.4. Revenue
            15.3.1.5. Strategy & Business Overview
        15.3.2. MDxHealth
            15.3.2.1. Company Overview
            15.3.2.2. Sales Area
            15.3.2.3. Geographical Presence
            15.3.2.4. Revenue
            15.3.2.5. Strategy & Business Overview
        15.3.3. Myriad Genetics, Inc.
            15.3.3.1. Company Overview
            15.3.3.2. Sales Area
            15.3.3.3. Geographical Presence
            15.3.3.4. Revenue
            15.3.3.5. Strategy & Business Overview
        15.3.4. Bio-Rad Laboratories
            15.3.4.1. Company Overview
            15.3.4.2. Sales Area
            15.3.4.3. Geographical Presence
            15.3.4.4. Revenue
            15.3.4.5. Strategy & Business Overview
        15.3.5. QIAGEN
            15.3.5.1. Company Overview
            15.3.5.2. Sales Area
            15.3.5.3. Geographical Presence
            15.3.5.4. Revenue
            15.3.5.5. Strategy & Business Overview
        15.3.6. F. Hoffmann-La Roche Ltd.
            15.3.6.1. Company Overview
            15.3.6.2. Sales Area
            15.3.6.3. Geographical Presence
            15.3.6.4. Revenue
            15.3.6.5. Strategy & Business Overview
        15.3.7. Thermo Fisher Scientific, Inc.
            15.3.7.1. Company Overview
            15.3.7.2. Sales Area
            15.3.7.3. Geographical Presence
            15.3.7.4. Revenue
            15.3.7.5. Strategy & Business Overview
        15.3.8. Genomic Health, Inc.
            15.3.8.1. Company Overview
            15.3.8.2. Sales Area
            15.3.8.3. Geographical Presence
            15.3.8.4. Revenue
            15.3.8.5. Strategy & Business Overview
        15.3.9. Illumina, Inc.
            15.3.9.1. Company Overview
            15.3.9.2. Sales Area
            15.3.9.3. Geographical Presence
            15.3.9.4. Revenue
            15.3.9.5. Strategy & Business Overview
        15.3.10. Other Key Players
            15.3.10.1. Company Overview
            15.3.10.2. Sales Area
            15.3.10.3. Geographical Presence
            15.3.10.4. Revenue
            15.3.10.5. Strategy & Business Overview

16. Go to Market Strategy
17. Identification of Potential Market Spaces
18. Prevailing Market Risks
19. Understanding Buying Process of Customers
20. Preferred Sales & Marketing Strategy

List of Tables

Table 1: Global Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031

Table 2: Global Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031

Table 3: Global Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031

Table 4: Global Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031

Table 5: North America Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031

Table 6: North America Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031

Table 7: North America Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031

Table 8: North America Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031

Table 9: Europe Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031

Table 10: Europe Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031

Table 11: Europe Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031

Table 12: Europe Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031

Table 13: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031

Table 14: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031

Table 15: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031

Table 16: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031

Table 17: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031

Table 18: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031

Table 19: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031

Table 20: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031

Table 21: South America Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031

Table 22: South America Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031

Table 23: South America Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031

Table 24: South America Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031

List of Figures

Figure 1: Global Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031

Figure 2: Global Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031

Figure 3: Global Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031

Figure 4: Global Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031

Figure 5: Global Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031

Figure 6: Global Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031

Figure 7: Global Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031

Figure 8: Global Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031

Figure 9: North America Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031

Figure 10: North America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031

Figure 11: North America Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031

Figure 12: North America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031

Figure 13: North America Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031

Figure 14: North America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031

Figure 15: North America Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031

Figure 16: North America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031

Figure 17: Europe Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031

Figure 18: Europe Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031

Figure 19: Europe Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031

Figure 20: Europe Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031

Figure 21: Europe Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031

Figure 22: Europe Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031

Figure 23: Europe Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031

Figure 24: Europe Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031

Figure 25: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031

Figure 26: Asia Pacific Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031

Figure 27: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031

Figure 28: Asia Pacific Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031

Figure 29: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031

Figure 30: Asia Pacific Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031

Figure 31: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031

Figure 32: Asia Pacific Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031

Figure 33: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031

Figure 34: Middle East & Africa Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031

Figure 35: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031

Figure 36: Middle East & Africa Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031

Figure 37: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031

Figure 38: Middle East & Africa Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031

Figure 39: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031

Figure 40: Middle East & Africa Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031

Figure 41: South America Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031

Figure 42: South America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031

Figure 43: South America Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031

Figure 44: South America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031

Figure 45: South America Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031

Figure 46: South America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031

Figure 47: South America Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031

Figure 48: South America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031